Kirsten K. Viktil

2.3k total citations
37 papers, 1.7k citations indexed

About

Kirsten K. Viktil is a scholar working on Geriatrics and Gerontology, Emergency Medical Services and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kirsten K. Viktil has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Geriatrics and Gerontology, 11 papers in Emergency Medical Services and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kirsten K. Viktil's work include Pharmaceutical Practices and Patient Outcomes (25 papers), Patient Safety and Medication Errors (11 papers) and Pharmaceutical studies and practices (10 papers). Kirsten K. Viktil is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (25 papers), Patient Safety and Medication Errors (11 papers) and Pharmaceutical studies and practices (10 papers). Kirsten K. Viktil collaborates with scholars based in Norway, France and United States. Kirsten K. Viktil's co-authors include Hege Salvesen Blix, Tron Anders Moger, Aasmund Reikvam, Sabine Ruths, Åsmund Reikvam, Anne Gerd Granås, Kjell H. Halvorsen, Beate Hennie Garcia, Espen Molden and Tore K Kvien and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Nephrology Dialysis Transplantation.

In The Last Decade

Kirsten K. Viktil

34 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirsten K. Viktil Norway 20 1.2k 405 368 336 325 37 1.7k
Leslie Fish United States 13 1.2k 1.0× 345 0.9× 416 1.1× 356 1.1× 414 1.3× 16 1.9k
Benoît Allenet France 26 1.2k 1.0× 335 0.8× 457 1.2× 453 1.3× 282 0.9× 119 2.1k
Tommy Eriksson Sweden 22 1.0k 0.9× 192 0.5× 457 1.2× 338 1.0× 312 1.0× 57 1.4k
Jo‐anne E Brien Australia 23 1.0k 0.8× 313 0.8× 503 1.4× 442 1.3× 394 1.2× 97 2.0k
Catherine I. Lindblad United States 11 1.0k 0.8× 205 0.5× 181 0.5× 278 0.8× 492 1.5× 13 1.2k
Ronald L. Castelino Australia 23 884 0.7× 245 0.6× 129 0.4× 457 1.4× 444 1.4× 103 1.7k
Mary G. Amato United States 23 797 0.7× 172 0.4× 349 0.9× 275 0.8× 283 0.9× 57 2.0k
Kurt E. Hersberger Switzerland 27 1.7k 1.4× 632 1.6× 294 0.8× 967 2.9× 539 1.7× 138 2.9k
Jacob Abarca United States 15 682 0.6× 209 0.5× 287 0.8× 145 0.4× 103 0.3× 31 1.2k
Anne Gerd Granås Norway 20 595 0.5× 364 0.9× 157 0.4× 181 0.5× 286 0.9× 61 1.2k

Countries citing papers authored by Kirsten K. Viktil

Since Specialization
Citations

This map shows the geographic impact of Kirsten K. Viktil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten K. Viktil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten K. Viktil more than expected).

Fields of papers citing papers by Kirsten K. Viktil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten K. Viktil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten K. Viktil. The network helps show where Kirsten K. Viktil may publish in the future.

Co-authorship network of co-authors of Kirsten K. Viktil

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten K. Viktil. A scholar is included among the top collaborators of Kirsten K. Viktil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten K. Viktil. Kirsten K. Viktil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Øie, Erik, et al.. (2022). Drug-related emergency department visits: prevalence and risk factors. Internal and Emergency Medicine. 17(5). 1453–1462. 15 indexed citations
3.
Walter, Scott R., et al.. (2021). Emergency department physicians’ distribution of time in the fast paced-workflow-a novel time-motion study of drug-related activities. International Journal of Clinical Pharmacy. 44(2). 448–458. 10 indexed citations
4.
Ritschl, Valentin, Tanja Stamm, Daniel Aletaha, et al.. (2020). 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice. Annals of the Rheumatic Diseases. 80(6). 707–713. 34 indexed citations
5.
6.
Moger, Tron Anders, et al.. (2015). Drug safety at admission to emergency department: an innovative model for PRIOritizing patients for MEdication Reconciliation (PRIOMER). European Journal of Emergency Medicine. 24(5). 333–339. 19 indexed citations
7.
Garcia, Beate Hennie, et al.. (2014). Should nurses or clinical pharmacists perform medication reconciliation? A randomized controlled trial. European Journal of Clinical Pharmacology. 70(11). 1325–1332. 28 indexed citations
8.
Blix, Hege Salvesen, Kirsten K. Viktil, Tron Anders Moger, & Aasmund Reikvam. (2010). Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients. Pharmacy Practice. 8(1). 50–5. 66 indexed citations
9.
Halvorsen, Kjell H., Sabine Ruths, Anne Gerd Granås, & Kirsten K. Viktil. (2010). Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scandinavian Journal of Primary Health Care. 28(2). 82–88. 69 indexed citations
10.
Viktil, Kirsten K., Hege Salvesen Blix, & Åsmund Reikvam. (2009). The Janus face of polypharmacy – overuse versus underuse of medication. Norsk Epidemiologi. 18(2). 14 indexed citations
11.
Viktil, Kirsten K., Anders Engeland, & Kari Furu. (2009). Use of antirheumatic drugs in mothers and fathers before and during pregnancy—a population‐based cohort study. Pharmacoepidemiology and Drug Safety. 18(8). 737–742. 11 indexed citations
12.
Viktil, Kirsten K. & Hege Salvesen Blix. (2008). The Impact of Clinical Pharmacists on Drug‐Related Problems and Clinical Outcomes. Basic & Clinical Pharmacology & Toxicology. 102(3). 275–280. 172 indexed citations
13.
Blix, Hege Salvesen, Kirsten K. Viktil, Tron Anders Moger, & Aasmund Reikvam. (2008). Identification of drug interactions in hospitals – computerized screening vs. bedside recording. Journal of Clinical Pharmacy and Therapeutics. 33(2). 131–139. 28 indexed citations
14.
Ruths, Sabine, Kirsten K. Viktil, & Hege Salvesen Blix. (2007). Klassifisering av legemiddelrelaterte problemer. BIBSYS Brage (BIBSYS (Norway)). 4 indexed citations
15.
Ruths, Sabine, Kirsten K. Viktil, & Hege Salvesen Blix. (2007). [Classification of drug-related problems].. PubMed. 127(23). 3073–6. 107 indexed citations
16.
Viktil, Kirsten K., Hege Salvesen Blix, Tron Anders Moger, & Aasmund Reikvam. (2006). Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug‐related problems. British Journal of Clinical Pharmacology. 63(2). 187–195. 403 indexed citations
17.
Viktil, Kirsten K., Hege Salvesen Blix, Tron Anders Moger, & Aasmund Reikvam. (2006). Interview of patients by pharmacists contributes significantly to the identification of drug‐related problems (DRPs). Pharmacoepidemiology and Drug Safety. 15(9). 667–674. 48 indexed citations
18.
Blix, Hege Salvesen, et al.. (2004). The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. European Journal of Clinical Pharmacology. 60(9). 651–658. 167 indexed citations
19.
Kvien, Tore K & Kirsten K. Viktil. (2003). Pharmacotherapy for regional musculoskeletal pain. Best Practice & Research Clinical Rheumatology. 17(1). 137–150. 10 indexed citations
20.
Viktil, Kirsten K., et al.. (2001). Polypharmacy among patients admitted to hospital with rheumatic diseases.. Pharmacy World & Science. 23(4). 153–158. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie Fish Breakdown of academic impact, for papers by Benoît Allenet Breakdown of academic impact, for papers by Tommy Eriksson Breakdown of academic impact, for papers by Jo‐anne E Brien Breakdown of academic impact, for papers by Catherine I. Lindblad Breakdown of academic impact, for papers by Ronald L. Castelino Breakdown of academic impact, for papers by Mary G. Amato Breakdown of academic impact, for papers by Kurt E. Hersberger Breakdown of academic impact, for papers by Jacob Abarca Breakdown of academic impact, for papers by Anne Gerd Granås
Rankless by CCL
2026